Press release
Smart Inhalers Market Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2028
Global Smart Inhalers Market is expected to reach the market valuation of USD 1751.7 million by 2028 expanding at a reasonable CAGR of 20.5% during the forecast period (2021-2028) from USD 390.1 million in 2020. A Smart inhaler is an advanced form of inhalers that can be connected to applications on a phone or tablet via Bluetooth, helping doctors to manage a patient’s respiratory condition more effectively.The various factors driving the growth of the smart inhaler market include the rise in pulmonary disease incidences, technological advancements, and the increased awareness among end-users led by adopting digital inhalers for monitoring these diseases. Also, nearly half of the country’s population are suffering from chronic illnesses, including lung cancer, COPD, or asthma which makes the situation more grave. As a result, many more people are inclining towards preventive healthcare increasing the worldwide adoption rates of smart inhalers. For instance, 1.8 million deaths were recorded due to lung cancer across the world in 2020, accounting for the highest number of deaths due to cancer.
Request for full report- https://univdatos.com/request_form/form/407
Furthermore, the rising health concerns among the geriatric population coupled with the surging cost of healthcare procedures is the major reason for the shift towards smart inhalers. For instance, according to the Peterson-KFF health system tracker, the general cost of inpatient hospital admission rose steeply by 85% over the decade. In addition to this, medical costs for surgical and medical care nearly doubled from 2008 to 2018. In view of these facts, the demand for more accessible, personalized, and cost-effective health solutions propelling the growth of the smart inhalers market all over the world.
However, The major restraints that are affecting the market of smart inhalers include data security issues and the high cost of smart inhalers. In addition to this, a lack of awareness about the symptoms of COPD and asthma is impeding the growth of this market all over the world.
The COVID-19 pandemic has disrupted the entire world and many industries. This worldwide disruption has affected the healthcare industry like never before and has greatly impacted the way healthcare is delivered across the world. With the lockdown restrictions all over the world, there is surging demand for digital healthcare technologies enabling patients to get assistance for maintaining their physical and mental health. In addition to this, deferred and canceled treatment for chronic respiratory diseases has further increased the worldwide demand for smart inhalers.
For a detailed analysis of the market drivers of smart inhalers browse through - https://univdatos.com/report/smart-inhalers-market
The smart inhalers market is boosting owing to numerous startups and new product innovations driving its worldwide popularity. For example, In November 2019, Lupin, a pharma major launched “ADHERO,” a new connected smart device for metered-dose inhalers. This first-of-its-kind device is designed to help patients with chronic respiratory diseases to track their MDI usage and facilitate improved adherence to therapy.
Based on Product, the market has been segmented into inhalers and nebulizers. The inhalers segment held the major market share and is anticipated to maintain its dominance over the projected timeframe. Further, the inhalers are sub-segmented into Metered Dose Inhalers and Dry Powder Inhalers. The largest market share has been acquired by the inhalers segment and is expected to grow at --% CAGR during the forecast period (2021-2028) owing to the growing incidences of respiratory diseases (such as asthma and COPD) across the world which requires regular monitoring of the patient. Thus, reducing the risk of patient mortality and emergency hospital visits.
For a detailed analysis of the products of smart inhalers browse through - https://univdatos.com/report/smart-inhalers-market
Based on indication, the global smart inhaler market is segmented into Chronic Obstructive Pulmonary Disorder (COPD) and asthma. Asthma occupied the largest share and is expected to maintain its dominance throughout the forecast period 2021-2028 as asthma is one of the leading causes of death globally. The segment generated revenue of US$ -- million in 2020. However, the COPD segment is also anticipated to grow exponentially owing to the high mortality rates due to COPD all over the world. Chronic Obstructive Pulmonary Disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. For instance, According to the National Institutes of Health Trusted Source (NIH), around 24 million in America alone have COPD. Amongst the prevalence of COPD and asthma, COPD is expected to be the third leading cause of death globally by 2030. COPD is a life-threatening disease that accounts for about 5% of the yearly global deaths. Hence, the increasing prevalence of COPD and asthma will provide growth to the smart inhaler market over the forecast period.
Request for Sample of the report browse through - https://univdatos.com/request_form/form/407
Additionally, the report provides detailed report also provides insights of global smart inhalers market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD -- billion in 2020 owing to the surge in the number of chronic respiratory disease incidences and the growing geriatric population in the region. For instance, according to the U.S. Census Bureau, the U.S. population will grow by 79 million people, from about 326 million in 2018 to 404 million by 2060, and will cross the 400-million threshold in 2058. As a result, there will be much more demand than supply in the healthcare sector eventually increasing the healthcare costs. At the same time, Asia-pacific regions are identified as potential markets offering significant growth opportunities for several startups and other major players in the field of smart inhalers.
Boehringer Ingelheim, Cohero Health, Inc., Novartis, AstraZeneca, Omron Corporation, Teva Pharmaceuticals Industries Ltd., Vectura Group, GlaxoSmithKline, Adherium Limited, 3M are some of the key players operating in the global smart inhaler market. Several M&As along with partnerships have been undertaken by these players to develop the smart inhaler.
Request for full report-https://univdatos.com/report/smart-inhalers-market/
Global Smart Inhaler Market Segmentation
Market Insight, by Product
Inhalers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Nebulizers
Market Insight, by Indication
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Market Insight, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Channel
Market Insight, by End-User
Hospital Pharmacies
Retail Pharmacies
Online Channel
Market Insight, by Region
North America
United States
Canada
Rest of North America
Europe
France
Germany
Italy
Spain
United Kingdom
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World
Top Company Profiles
Boehringer Ingelheim
Cohero Health, Inc.
Novartis
AstraZeneca
Omron Corporation
Teva Pharmaceuticals Industries Ltd.
Vectura Group
GlaxoSmithKline
Adherium Limited
3M
CONTACT US
E-mail: sales@univdatos.com
Phone: +91 783860491
Address-: 4th & 5th Floor,
C80B, Sector 8, Noida,
Pin code- 201301, UP, India
About UnivDatos Market Insights
UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smart Inhalers Market Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2028 here
News-ID: 2451263 • Views: …
More Releases from UnivDatos Market Insights (UMI)

Airline Route Profitability Software Market - Industry Size, Share, Growth & For …
The Airline Route Profitability Software Market is expected to grow at a steady rate of around 10% owing to the increased adoption of technologies such as artificial intelligence, mobile and conversational commerce coupled with business analytics and market intelligence. Thus, helping airlines to identify demand trends and increase profit margins by calculating and evaluating the cost of currently operated routes. Moreover, the rising need to find shorter as well as…

Building Energy Management System Market - Industry Size, Share, Growth & Foreca …
Global Building Energy Management System market is expected to register a CAGR of around 11% over the period of 2022-2028. A building energy management system (BEMS) is a computer-based system that monitors and controls a building's electrical and mechanical equipment such as lighting, power systems, heating, and ventilation. Growth in technological advancement has made building energy management systems a vital component for managing energy demand, especially in large building sites.…

Cloud Computing Market - Industry Analysis by Size, Share, Growth & Forecast (20 …
Internet penetration rate and data generated yearly are some of the most prominent factors driving the growth of the cloud computing market because as the size of generated data increases the need for this data to be stored either in physical storage devices or in cloud storage also increases. Moreover, physical storage devices are easy to access but they are more expensive and less secure than cloud storage, there is…

Perimeter Security Market Report 2022 - Global Business Trends, Emerging Growth, …
Perimeter security refers to an integrated system that enables the physical security of a facility. It helps in protecting against unauthorized physical intrusion. Outdoor perimeter security includes technologies such as video surveillance systems, access control systems, communication and notification systems, and intruder detection systems. Recent technological advances have introduced infrared, microwave, radar, and seismic sensors. This has contributed to the robustness of these systems.
Download a Sample Copy of this Report…
More Releases for COPD
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858
The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market…
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would…
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the…
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the…